Literature DB >> 12379168

The myocardial ischemia reduction with aggressive cholesterol lowering study.

Peter W F Wilson.   

Abstract

Entities:  

Year:  2002        PMID： 12379168

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  9 in total

1.  Lipid-lowering therapy in acute coronary syndromes.

Authors:  F M Sacks
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

2.  A new feature on the cholesterol-lowering landscape.

Authors:  D J Rader
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

3.  Antioxidant versus lipid-altering therapy--some answers, more questions.

Authors:  J E Freedman
Journal:  N Engl J Med       Date:  2001-11-29       Impact factor: 91.245

4.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

Authors:  G G Schwartz; A G Olsson; M D Ezekowitz; P Ganz; M F Oliver; D Waters; A Zeiher; B R Chaitman; S Leslie; T Stern
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

5.  Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

Authors:  B G Brown; X Q Zhao; A Chait; L D Fisher; M C Cheung; J S Morse; A A Dowdy; E K Marino; E L Bolson; P Alaupovic; J Frohlich; J J Albers
Journal:  N Engl J Med       Date:  2001-11-29       Impact factor: 91.245

6.  Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits.

Authors:  S J Hutchison; M S Reitz; K Sudhir; R E Sievers; B Q Zhu; Y P Sun; T M Chou; P C Deedwania; K Chatterjee; S A Glantz; W W Parmley
Journal:  Hypertension       Date:  1997-05       Impact factor: 10.190

7.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Authors:  H B Rubins; S J Robins; D Collins; C L Fye; J W Anderson; M B Elam; F H Faas; E Linares; E J Schaefer; G Schectman; T J Wilt; J Wittes
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

8.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

9.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.